170 related articles for article (PubMed ID: 32155134)
1. Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis.
Nayak K; Jain V; Kaur M; Khan N; Gottimukkala K; Aggarwal C; Sagar R; Gupta S; Rai RC; Dixit K; Islamuddin M; Khan WH; Verma A; Maheshwari D; Chawla YM; Reddy ES; Panda H; Sharma P; Bhatnagar P; Singh P; Raghavendhar B S; Patel AK; Ratageri VH; Chandele A; Ray P; Murali-Krishna K
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32155134
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
3. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.
Verma A; Nayak K; Chandele A; Singla M; Ratageri VH; Lodha R; Kabra SK; Murali-Krishna K; Ray P
Arch Virol; 2021 Jul; 166(7):1913-1920. PubMed ID: 33907861
[TBL] [Abstract][Full Text] [Related]
4. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
[TBL] [Abstract][Full Text] [Related]
5. The neutralizing role of IgM during early Chikungunya virus infection.
Chua CL; Sam IC; Chiam CW; Chan YF
PLoS One; 2017; 12(2):e0171989. PubMed ID: 28182795
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
Fumagalli MJ; de Souza WM; Espósito DLA; Silva A; Romeiro MF; Martinez EZ; da Fonseca BAL; Figueiredo LTM
Virol J; 2018 Jul; 15(1):112. PubMed ID: 30041676
[TBL] [Abstract][Full Text] [Related]
7. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
Fox JM; Diamond MS
J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
[TBL] [Abstract][Full Text] [Related]
8. Disease Resolution in Chikungunya-What Decides the Outcome?
Srivastava P; Kumar A; Hasan A; Mehta D; Kumar R; Sharma C; Sunil S
Front Immunol; 2020; 11():695. PubMed ID: 32411133
[TBL] [Abstract][Full Text] [Related]
9. Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection.
Patil HP; Gosavi M; Mishra AC; Arankalle VA
Am J Trop Med Hyg; 2021 Feb; 104(4):1438-1443. PubMed ID: 33617471
[TBL] [Abstract][Full Text] [Related]
10. Evidence of chikungunya virus infection among febrile patients in northwest Ethiopia.
Ferede G; Tiruneh M; Abate E; Wondimeneh Y; Gadisa E; Howe R; Aseffa A; Tessema B
Int J Infect Dis; 2021 Mar; 104():183-188. PubMed ID: 33373719
[TBL] [Abstract][Full Text] [Related]
11. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
12. Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control.
Antonio VS; Amade NA; Muianga AF; Ali S; Monteiro V; Mula F; Chelene I; Oludele J; Chongo I; José A; Augusto O; Gudo ES
PLoS One; 2019; 14(3):e0213941. PubMed ID: 30897135
[TBL] [Abstract][Full Text] [Related]
13. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
Prince HE; Seaton BL; Matud JL; Batterman HJ
Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of antibodies against Chikungunya, Dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar.
Schwarz NG; Girmann M; Randriamampionona N; Bialonski A; Maus D; Krefis AC; Njarasoa C; Rajanalison JF; Ramandrisoa HD; Randriarison ML; May J; Schmidt-Chanasit J; Rakotozandrindrainy R
Emerg Infect Dis; 2012 Nov; 18(11):1780-6. PubMed ID: 23092548
[TBL] [Abstract][Full Text] [Related]
15. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.
Kose N; Fox JM; Sapparapu G; Bombardi R; Tennekoon RN; de Silva AD; Elbashir SM; Theisen MA; Humphris-Narayanan E; Ciaramella G; Himansu S; Diamond MS; Crowe JE
Sci Immunol; 2019 May; 4(35):. PubMed ID: 31101672
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of chikungunya virus infection in five hospitals within Anyigba, Kogi State of Nigeria.
Omatola CA; Onoja BA; Fassan PK; Osaruyi SA; Iyeh M; Samuel MA; Haruna PU
Braz J Infect Dis; 2020; 24(1):1-6. PubMed ID: 32001210
[TBL] [Abstract][Full Text] [Related]
17. Detection of Chikungunya Virus in Nepal.
Pandey BD; Neupane B; Pandey K; Tun MM; Morita K
Am J Trop Med Hyg; 2015 Oct; 93(4):697-700. PubMed ID: 26195462
[TBL] [Abstract][Full Text] [Related]
18. Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.
Kim YC; López-Camacho C; Garcia-Larragoiti N; Cano-Mendez A; Hernandez-Flores KG; Domínguez-Alemán CA; Mar MA; Vivanco-Cid H; Viveros-Sandoval ME; Reyes-Sandoval A
Viruses; 2019 May; 11(5):. PubMed ID: 31052472
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
[TBL] [Abstract][Full Text] [Related]
20. Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.
Jain J; Kaur N; Haller SL; Kumar A; Rossi SL; Narayanan V; Kumar D; Gaind R; Weaver SC; Auguste AJ; Sunil S
Am J Trop Med Hyg; 2020 Apr; 102(4):857-868. PubMed ID: 32067624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
